SEAFIELD CAPITAL CORP
DEF 14A, 1995-04-17
MEDICAL LABORATORIES
Previous: FIRST TRUST COMBINED SERIES 43, 24F-2NT, 1995-04-17
Next: FIRST TRUST COMBINED SERIES 44, 24F-2NT, 1995-04-17



<PAGE>
                            SCHEDULE 14A INFORMATION

                  Proxy Statement Pursuant to Section 14(a) of
            the Securities Exchange Act of 1934 (Amendment No.    )

    Filed by the Registrant / /
    Filed by a Party other than the Registrant /X/

    Check the appropriate box:
    / /  Preliminary Proxy Statement
    / /  Confidential, for Use of the Commission Only (as permitted by Rule
         14a-6(e)(2))
    /X/  Definitive Proxy Statement
    / /  Definitive Additional Materials
    / /  Soliciting  Material  Pursuant  to  Section  240.14a-11(c)  or  Section
         240.14a-12
                       Seafield Capital Corporation
- --------------------------------------------------------------------------------
                (Name of Registrant as Specified In Its Charter)
                           Merrill Corporation
- --------------------------------------------------------------------------------
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

/X/  $125 per  Exchange Act  Rules 0-11(c)(1)(ii),  14a-6(i)(1), 14a-6(i)(2)  or
     Item 22(a)(2) of Schedule 14A.
/ /  $500  per  each party  to  the controversy  pursuant  to Exchange  Act Rule
     14a-6(i)(3).
/ /  Fee  computed  on   table  below   per  Exchange   Act  Rules   14a-6(i)(4)
     and 0-11.
     1) Title of each class of securities to which transaction applies:
                        --
        ------------------------------------------------------------------------
     2) Aggregate number of securities to which transaction applies:
                        --
        ------------------------------------------------------------------------
     3) Per unit price or other underlying value of transaction computed
        pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
        filing fee is calculated and state how it was determined):
                        N/A
        ------------------------------------------------------------------------
     4) Proposed maximum aggregate value of transaction:
                        N/A
        ------------------------------------------------------------------------
     5) Total fee paid:
                         --
        ------------------------------------------------------------------------
/ /  Fee paid previously with preliminary materials.
/ /  Check box if any part of the fee is offset as provided by Exchange Act Rule
     0-11(a)(2)  and identify the  filing for which the  offsetting fee was paid
     previously. Identify the previous filing by registration statement  number,
     or the Form or Schedule and the date of its filing.
     1) Amount Previously Paid:
        ------------------------------------------------------------------------
     2) Form, Schedule or Registration Statement No.:
        ------------------------------------------------------------------------
     3) Filing Party:
        ------------------------------------------------------------------------
     4) Date Filed:
        ------------------------------------------------------------------------
<PAGE>
                                     [LOGO]

                          SEAFIELD CAPITAL CORPORATION
                        2600 Grand Boulevard, Suite 500
                          Kansas City, Missouri 64108

                            ------------------------

                    NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
                           To be held on May 17, 1995

                            ------------------------

    The  Annual  Meeting of  Shareholders of  Seafield Capital  Corporation (the
"Company") will be held on Wednesday May 17, 1995, at 10:00 a.m., local time  at
the  Westin Crown Center Hotel -- Shawnee  Mission Room, located at One Pershing
Road, Kansas City, Missouri, for the following purposes:

    1.  To  elect three (3)  directors, each to  serve for a  term of three  (3)
       years;

    2.   To  ratify the appointment  of KPMG  Peat Marwick LLP  as the Company's
       independent auditors for the year ending December 31, 1995; and

    3.  To transact such other business as may properly come before the  meeting
       or any adjournment thereof.

    The  Board of Directors of the Company has established March 29, 1995 as the
record date for the meeting. Shareholders of record at the close of business  on
that  day will be  entitled to vote  at the Annual  Meeting and any adjournments
thereof.

    You are cordially invited to attend this meeting. It is important that  your
stock be represented at the meeting. Even if you plan to attend the meeting, you
are  urged  to complete,  sign and  return the  enclosed proxy  card as  soon as
possible to ensure that your shares will  be represented at the meeting. If  you
attend the meeting, you may revoke your proxy by voting in person.

                                          By Order of the Board of Directors,
                                          [SIG]
                                          W. T. GRANT II
                                          CHAIRMAN OF THE BOARD

                                          [SIG]
                                          STEVEN K. FITZWATER
                                          SECRETARY

April 17, 1995
<PAGE>
                          SEAFIELD CAPITAL CORPORATION
                        2600 Grand Boulevard, Suite 500
                          Kansas City, Missouri 64108

                            ------------------------

                                PROXY STATEMENT
                               ------------------

                         ANNUAL MEETING OF SHAREHOLDERS
                           to be held on May 17, 1995

                            ------------------------

                                  INTRODUCTION

    This  Proxy Statement  is being  furnished to  the shareholders  of Seafield
Capital Corporation, a Missouri corporation (the "Company"), in connection  with
the  solicitation of proxies by the Board of Directors of the Company for use at
the Annual Meeting of Shareholders of the  Company to be held on Wednesday,  May
17,  1995, and any adjournments thereof.  The address of the principal executive
offices of the Company is 2600 Grand Boulevard, Suite 500, Kansas City, Missouri
64108. The telephone number at that address is (816) 842-7000. The  distribution
to  shareholders of this  Proxy Statement, together  with the accompanying proxy
materials, will commence on or about April 17, 1995.

    At the Annual  Meeting, shareholders will  be asked to  (i) elect three  (3)
directors,  each to  serve for a  term of three  (3) years, and  (ii) ratify the
appointment of KPMG Peat Marwick LLP  as the Company's independent auditors  for
the year ending December 31, 1995, all as set forth in the Proxy Statement.

                               VOTING AND PROXIES

    The  Board of Directors of the Company has established March 29, 1995 as the
record date  for  the meeting.  Only  shareholders of  record  at the  close  of
business  on the record date are entitled to notice of and to vote at the Annual
Meeting, and any adjournments  thereof. At the close  of business on the  record
date,  the Company had  outstanding 6,419,138 shares of  Common Stock, par value
$1.00 per  share ("Common  Stock"  or "Company  Common  Stock"). Each  share  of
Company  Common Stock  outstanding on  the record date  is entitled  to one vote
except in  the case  of  the election  of  directors wherein  cumulative  voting
applies.  The presence  in person  or by  proxy of  the holders  of record  of a
majority of the shares of Company Common Stock entitled to a vote at the  Annual
Meeting  shall  constitute  a quorum  for  the  transaction of  business  at the
meeting.

    Shares of  Common  Stock  may  be voted  cumulatively  in  the  election  of
directors  and  directors  are  elected  by  plurality  vote.  See  "ELECTION OF
DIRECTORS." The affirmative vote of the holders  of a majority of the shares  of
Common  Stock present in person or by proxy at the Annual Meeting is required to
ratify the appointment  of KPMG Peat  Marwick LLP as  the Company's  independent
auditors for 1995.

    There is no definitive statutory or case law authority in Missouri as to the
proper  treatment of votes withheld in  the election of directors or abstentions
or broker  non-votes  respecting  any  other matter  submitted  for  a  vote  of
shareholders.  The Company  believes withheld  votes and  abstentions and broker
non-votes should be  counted for  purposes of  determining whether  a quorum  is
present at the Annual Meeting for the transaction of business. In the absence of
controlling  precedent  to  the  contrary, the  Company  intends  to  treat such
withheld votes, abstentions and broker non-votes in this manner.

                                       1
<PAGE>
    All shares of Company Common Stock  represented by a properly executed  form
of  proxy received by the Board of  Directors pursuant to this solicitation will
be voted in accordance with the instructions, if any, given in such proxy. If  a
form  of proxy  is duly executed  but does not  specify the manner  in which the
shares should be voted  on any matter  or matters, the proxy  will be voted  for
each  of  the  nominees  for  director  herein  referred  to  (see  "ELECTION OF
DIRECTORS")  and  otherwise  in  accordance  with  the  recommendations  of  the
Company's  Board of Directors as set forth herein. A proxy may be revoked at any
time prior to the exercise thereof by a notice from the shareholder received  in
writing  by the Secretary of the Company,  by submission of a duly executed form
of proxy bearing a later date, or by voting in person at the Annual Meeting.

    The entire cost of this proxy solicitation will be borne by the Company. The
Company  will  make   arrangements  with  brokerage   firms,  banks,   nominees,
fiduciaries  and other custodians to supply proxy materials to beneficial owners
of Company Common Stock and will reimburse them for their expenses in so  doing.
In  addition to solicitation by mail, proxies may be solicited by the directors,
officers  and  employees  of  the  Company  by  personal  interview,  telegraph,
telephone  or additional mailings.  Such directors, officers  and employees will
not be additionally compensated for such solicitation, but may be reimbursed for
expenses in connection therewith.

                             ELECTION OF DIRECTORS

    The Board of Directors  of the Company presently  consists of ten  directors
and  is  divided  into three  classes,  two  having three  and  one  having four
directors. Proxies cannot be  voted for a greater  number of persons than  those
nominated.  Generally, one  class of  directors is  elected annually,  with each
director of that class elected for a term of three years.

    The Board  of Directors  has  nominated for  election  as directors  of  the
Company  at the 1995 Annual Meeting three  (3) nominees indicated below, each to
serve as a director  until the 1998  Annual Meeting and  until his successor  is
duly  elected and qualified.  All of the  nominees presently are  members of the
Board of  Directors. Each  nominee has  indicated his  willingness to  serve  if
elected  and it is not anticipated that  any nominee will become unavailable for
election. In the  event that any  nominee should become  unwilling or unable  to
serve as a director, it is intended that all duly executed proxies will be voted
for  the election of such other person, if any, as is designated by the Board of
Directors. If  no such  person is  designated  as a  replacement, the  Board  of
Directors  will make an appropriate  reduction in the number  of directors to be
elected.

    Under Missouri law and the  Company's Articles of Incorporation, shares  may
be  voted cumulatively in the election  of directors. Accordingly, a shareholder
is entitled to three  votes for each  share owned, one for  each director to  be
elected.  A shareholder's votes may  be cast equally among  all nominees, may be
cast in  favor of  a single  nominee or  may be  distributed among  two or  more
nominees.

    The  enclosed form of  proxy provides a method  for shareholders to withhold
authority to  vote for  any  one or  more of  the  nominees for  director  while
granting authority to vote for the remaining nominees. The names of all nominees
are  listed on the  proxy card. If you  wish to grant authority  to vote for all
nominees, check the box marked "FOR". If you wish to withhold authority to  vote
for all nominees, check the box marked "WITHHELD". If you wish your shares to be
voted  for some nominees  and not for one  or more of the  others, check the box
marked "FOR"  and  indicate the  name(s)  of the  nominee(s)  for whom  you  are
withholding  the authority to vote by writing  the name(s) on the blank provided
immediately below the "FOR" box.

    Unless authority to  vote for one  or more nominees  is withheld, all  votes
represented  by a properly executed proxy will  be cast equally among all of the
nominees listed  below.  If  authority to  vote  for  one or  more  nominees  is
withheld,  unless directions to the contrary are stated on the proxy card, votes
represented by  a  properly  executed  proxy will  be  cast  equally  among  the
remaining nominees. Directors are elected by a plurality vote.

                                       2
<PAGE>
    The  following table sets forth as to  each nominee, and as to each director
whose term continues after the 1995 Annual Meeting, such person's age, principal
occupation and business  experience during  the last five  years, positions  and
offices with the Company, certain other directorships held, involvement, if any,
in certain legal proceedings and the year such person first became a director.

NOMINEES FOR TERMS TO EXPIRE IN 1998
<TABLE>
<CAPTION>
                                          PRINCIPAL OCCUPATION, BUSINESS EXPERIENCE AND           DIRECTOR
           NAME             AGE                   OTHER DIRECTORSHIPS HELD (1)                    SINCE (2)
- --------------------------  ---  ---------------------------------------------------------------  ---------
<S>                         <C>  <C>                                                              <C>
John C. Gamble (3)          49   Managing  Partner  of the  law  firm of  Allen,  Matkins, Leck,      1989
                                  Gamble & Mallory, Irvine, California.
Michael E. Herman           53   Private investments since 1990  (partner Herman Family  Trading      1991
                                  Company); President of Kansas City Royals Baseball Team (major
                                  league baseball) since 1993; Chairman of the Finance Committee
                                  of Ewing Marion Kauffman Foundation since 1990; Executive Vice
                                  President  and Chief  Financial Officer,  Marion Laboratories,
                                  Inc. (pharmaceuticals)  from 1975  to 1990.  President,  Ewing
                                  Marion  Kauffman Foundation from 1985 to 1990. Mr. Herman also
                                  is a director of LabONE,  Inc., Boatmen's First National  Bank
                                  of  Kansas City, Cerner Corporation, Janus Capital Corporation
                                  and Agouron Pharmaceuticals, Inc.
James R. Seward             42   Executive Vice President of the Company since May 1993;  Senior      1990
                                  Vice  President  from  August  1990  to  May  1993  and  Chief
                                  Financial  Officer  since  1991;  Vice  President  --  Special
                                  Equities  from June  1988 to July  1990. Mr. Seward  also is a
                                  director of LabONE, Inc. and Response Technologies, Inc.

<CAPTION>

DIRECTORS WHOSE TERMS EXPIRE IN 1997
<S>                         <C>  <C>                                                              <C>

W.T. Grant II (3)(4)        44   Chief Executive Officer of the  Company; Chairman of the  Board      1980
                                  since May 1993; President prior to May 1993. Mr. Grant also is
                                  a  director of Commerce Bancshares,  Inc., Kansas City Power &
                                  Light Company, LabONE, Inc. and Response Technologies, Inc.
P. Anthony Jacobs           53   President of the  Company since  May 1993  and Chief  Operating      1987
                                  Officer  since  1990; Executive  Vice  President prior  to May
                                  1993. Mr. Jacobs also is  a director of Trenwick Group,  Inc.,
                                  LabONE, Inc. and Response Technologies, Inc.
David W. Kemper             44   Chairman  of the Board since 1991, President and director since      1982
                                  1982 and  Chief  Executive  Officer  since  1986  of  Commerce
                                  Bancshares, Inc. (bank holding company) and Chairman and Chief
                                  Executive  Officer and director of Commerce Bank of St. Louis,
                                  N.A. Mr. Kemper also is  a director of Venture, Inc.,  Ralcorp
                                  Holdings,  Inc.,  Wave Technologies  International,  Inc., and
                                  Tower Properties Company.
Dennis R. Stephen           45   Vice President --  Life Operations, and  since July 1994  Chief      1993
                                  Operating   Officer,  of  Tennessee   Farmers  Life  Insurance
                                  Companies (insurance).
</TABLE>

                                       3
<PAGE>
<TABLE>
<CAPTION>
DIRECTORS WHOSE TERMS EXPIRE IN 1996

                                          PRINCIPAL OCCUPATION, BUSINESS EXPERIENCE AND           DIRECTOR
           NAME             AGE                   OTHER DIRECTORSHIPS HELD (1)                    SINCE (2)
- --------------------------  ---  ---------------------------------------------------------------  ---------
<S>                         <C>  <C>                                                              <C>
Lan C. Bentsen              47   Investments; prior  to  its  sale  in  1994,  Mr.  Bentsen  was      1986
                                  Chairman  and  Chief Executive  Officer of  Sovereign National
                                  Management, Inc. (property management).
W. D. Grant (3)(4)          78   Consultant to the  Company since August  1990; Chairman of  the      1948
                                  Board  until May 1993. Mr. Grant also is a director of LabONE,
                                  Inc. and Boatmen's First National Bank of Kansas City.
John H. Robinson, Jr.       44   Managing Partner of Black  & Veatch (design and  construction).      1990
                                  Mr.  Robinson also  is a director  of Commerce  Bank of Kansas
                                  City, N.A.
<FN>
- ------------------------
(1)  Unless otherwise indicated, each nominee or continuing director who is  not
     an employee of the Company has held the position indicated as his principal
     occupation  for  at  least  the  past  five  years,  and  each  nominee and
     continuing director who is an officer  of the Company has held his  present
     position  with the  Company, or another  similar officer  position with the
     Company's former subsidiary,  Business Men's Assurance  Company of  America
     ("BMA"),  as his  principal occupation  for at  least the  past five years.
     LabONE,  Inc.   and   Response  Technologies,   Inc.   are   majority-owned
     subsidiaries of the Company.

(2)  The year shown is the year during which the individual named first became a
     director of either the Company or BMA.

(3)  Mr.  Gamble is the brother-in-law of W.T. Grant II and the son-in-law of W.
     D. Grant.

(4)  W. T. Grant II is the son of W. D. Grant.
</TABLE>

BOARD MEETINGS AND ATTENDANCE

    During 1994, the Board  of Directors held five  meetings and took action  by
unanimous  consent  on three  occasions.  Except for  Mr.  Bentsen, each  of the
nominees and continuing directors attended at least 75% of the aggregate of  all
meetings  of  the Board  of Directors  and  all committees  thereof on  which he
served.

COMMITTEES OF THE BOARD OF DIRECTORS

    The Company's  business is  under the  general management  of the  Board  of
Directors.   Under  authority  conveyed  by   the  Company's  Bylaws  to  create
committees, the Board of Directors  has established, among others, an  Executive
Committee,  a Nominating and Compensation Committee  and an Audit Committee. The
members of each such committee  are elected by a majority  of the full Board  of
Directors.

    To  the extent provided in the resolution authorizing its establishment and,
except to  the extent  otherwise  limited by  law,  the Executive  Committee  is
empowered  to exercise all authority of the Board of Directors in the management
of the Company. The  Executive Committee reports all  actions taken to the  full
Board  of  Directors at  its  next meeting.  The  Executive Committee,  which is
elected by a majority of the whole Board of Directors, presently comprises W. T.
Grant II, who is the chairman, John  C. Gamble, W. D. Grant, P. Anthony  Jacobs,
David  W. Kemper and  James R. Seward.  The Executive Committee  did not meet in
1994.

    The Nominating and  Compensation Committee establishes  the compensation  of
senior  management, approves salary increases  for elected officers, administers
the 1984 and 1989 Stock Option and Incentive Plans, monitors the  administration
of  employee  benefit  plans  and recommends  appropriate  changes  thereto, and
reviews  supplementary  pension  and  termination  arrangements  of  highly-paid

                                       4
<PAGE>
employees.  It  also  considers,  and  recommends  to  the  Board  of Directors,
candidates to serve  as directors  or consulting  directors of  the Company  and
persons  to be designated as executive vice presidents or senior vice presidents
of the  Company.  The Committee  will  consider suggestions  of  candidates  for
director  made by a shareholder if submitted  in writing by December 15th of the
year  next  preceding  an  annual  shareholders'  meeting,  accompanied  by  (a)
appropriate  biographical  material, (b)  a description  of all  arrangements or
understandings between such shareholder and each nominee and any other person or
persons pursuant to which the nomination or  nominations are to be made by  such
shareholder,  (c) such other information regarding each nominee proposed by such
shareholder as  would be  required to  be included  in a  proxy statement  filed
pursuant  to the proxy  rules of the Securities  and Exchange Commission ("SEC")
for a person nominated  by the Board  of Directors and (d)  the consent of  each
nominee  to serve as a  director of the Company,  if elected. The Nominating and
Compensation Committee presently comprises David W. Kemper, who is the chairman,
Lan C. Bentsen, John  C. Gamble, Michael  E. Herman, John  H. Robinson, Jr.  and
Dennis R. Stephen. The Nominating and Compensation Committee held one meeting in
1994.

    The  Audit  Committee  meets  periodically  with  management,  the  internal
auditing staff  and representatives  of the  Company's independent  auditors  to
assure  that appropriate audits of the Company's affairs are being conducted. In
carrying out these responsibilities,  the Audit Committee  reviews the scope  of
the  internal and external audit activities and the results of the annual audit.
The Audit Committee is also  responsible for recommending the public  accounting
firm  to  serve as  independent  auditors for  each  year. Both  the independent
auditors and the internal auditors have direct access to the Audit Committee  to
discuss  the results of their examinations,  the adequacy of internal accounting
controls and the integrity of financial reporting. The Audit Committee comprises
John H. Robinson,  Jr., who  is the  chairman, and  David W.  Kemper. The  Audit
Committee held three meetings in 1994.

COMPENSATION OF DIRECTORS

    GENERAL.   Each director who is not  a regularly compensated employee of the
Company ("Non-Employee Director")  is paid a  fee of $10,000  per annum for  his
services  as a director, plus a fee of  $750 for each Board of Directors meeting
attended and, if a member of one  or more committees, an additional fee of  $500
(or  $650 if such  person is the  chairman of the  committee) for each committee
meeting attended.  Non-Employee Directors  also are  provided $400,000  business
travel  accident insurance coverage ($1,000,000 in the  case of Mr. W. D. Grant,
who is  also a  consultant  to the  Company) for  all  business travel  and  are
reimbursed  for expenses incurred in  attending meetings. Non-Employee Directors
receive stock option  awards under  the Company's  1991 Non-Employee  Directors'
Stock  Option Plan upon becoming a director and are also entitled to participate
in the Stock Purchase Plan.

    STOCK PURCHASE PLAN.  The  Seafield Capital Corporation Stock Purchase  Plan
is  a stock  purchase plan which  is open  to all Non-Employee  Directors of the
Company who make a  one-time irrevocable election  to participate. Such  persons
may  contribute an amount equal to all or part of their directors' compensation.
Employees of the Company, and  of participating Company subsidiaries  designated
by the Chairman of the Board, may also participate by contributing the lesser of
2%   of  their  salary  or  $30,000.  The  Company  matches  each  participant's
contribution at a rate  of 50%. Company  Common Stock is  purchased on the  open
market  each  month  and  each  participant  receives  as  many  shares  as  his
contribution, plus  the  Company's  matching  contribution,  will  purchase.  No
employees  presently are designated by the  Chairman of the Board to participate
and, accordingly, none of the individuals or

                                       5
<PAGE>
members of the group identified in the Summary Compensation Table are  presently
eligible  to participate in the Stock  Purchase Plan. For 1994, matching Company
contributions for participating Non-Employee Directors were as follows:

<TABLE>
<CAPTION>
                                           MATCHING
                                           COMPANY
          NAME OF DIRECTOR              CONTRIBUTIONS
- ------------------------------------  ------------------
<S>                                   <C>
Lan C. Bentsen                            $    6,450
W. D. Grant                                    7,125
Michael E. Herman                              7,125
David W. Kemper                                7,950
John H. Robinson, Jr.                          8,100
Dennis R. Stephen                              3,563
</TABLE>

    1991  NON-EMPLOYEE   DIRECTORS'   STOCK  OPTION   PLAN   ("1991   DIRECTORS'
PLAN").    Under the  1991 Directors'  Plan, each  Non-Employee Director  of the
Company is entitled to a one time grant of options to purchase 15,000 shares  of
Company Common Stock at a price per share equal to 100% of the fair market value
of  a share of Company Common Stock on  the date the option is granted, with the
options becoming exercisable as follows: on  and after the first anniversary  of
the  date  of grant,  5,000 shares  may be  purchased; on  and after  the second
anniversary of the  date of grant,  5,000 additional shares  (a total of  10,000
shares)  may be purchased and on and after  the third anniversary of the date of
grant, 5,000 additional  shares (a  total of  15,000 shares)  may be  purchased;
subject,  however,  to the  limitation  that no  option  granted under  the 1991
Directors' Plan may be exercised more than ten years after the date of grant.

    Upon the termination of an option holder's term as a director, the option is
exercisable only as to those shares as to which the option could be exercised on
the date of  termination. All  rights under an  option terminate  to the  extent
unexercised ninety (90) days after the date a person ceases to be a director, if
termination  is for any reason other than  death, and twelve (12) months after a
director's date of death.

    Rights under an option also will  terminate in the event of the  liquidation
or  dissolution of the Company  or in the event of  a merger or consolidation in
which the Company is not the surviving corporation. However, a holder will  have
the right, immediately prior to such termination, to exercise an option in whole
or in part without regard to the foregoing installment exercise provisions.

    The  1991 Directors' Plan specifies that  each person who was a Non-Employee
Director on the date  the Company's shareholders approved  said Plan (i.e.,  May
15,  1991) would  be granted  an option as  of the  date of  such approval. Each
person who  is  thereafter elected  or  appointed  to serve  as  a  Non-Employee
Director  shall be entitled to  receive an option as of  the date of election or
appointment.

    In accordance with the foregoing and  pursuant to the 1991 Directors'  Plan,
the  following  current Non-Employee  Directors  have been  granted  options for
15,000 shares of  Common Stock.  Those held by  Dennis R.  Stephen were  granted
August  11,  1993, the  date  he was  first appointed  a  director, and  have an
exercise price  of $32.00  per share.  All of  the other  Non-Employee  Director
options  were granted May 15, 1991 and all  have an exercise price of $21.50 per
share:

<TABLE>
<CAPTION>
           NAME
- --------------------------
<S>                         <C>
Lan C. Bentsen
John C. Gamble
Michael E. Herman
W. D. Grant
David W. Kemper
John H. Robinson, Jr.
Dennis R. Stephen
</TABLE>

                                       6
<PAGE>
    Certain of the  options granted  to W.  D. Grant  and David  W. Kemper  were
exercised  prior to  1994. As  a result, Mr.  Grant presently  holds options for
5,000 shares and Mr. Kemper presently holds options for 10,000 shares under  the
1991 Directors' Plan. No other options granted to current Non-Employee Directors
under the 1991 Directors' Plan have been exercised.

    CONSULTING  AGREEMENT.   Mr.  W.  D. Grant  serves  as a  consultant  to the
Company, for  which he  was  paid an  annual retainer  of  $50,000 in  1994.  In
addition, pursuant to his consulting agreement, the Company reimbursed Mr. Grant
$5,000  for costs  incurred by  him in  1994 for  financial planning, investment
advisory and tax return preparation services.

CERTAIN TRANSACTIONS AND ARRANGEMENTS

    At the  time of  the  Company's sale  of  95% of  the  stock of  its  former
insurance  company subsidiary, BMA, in  July 1990, W. D. Grant  was a party to a
supplemental retirement agreement with BMA. Upon Mr. Grant's retirement from BMA
on July 31,  1990, he  began receiving payments  under such  agreement. In  June
1992,  the  Company  entered into  an  agreement  with, among  others,  the 1990
purchaser of BMA stock, pursuant to which  the Company sold the remaining 5%  of
the  stock and settled with the purchaser regarding a guaranty of BMA's mortgage
loan portfolio  which  the  Company  had  given  in  connection  with  the  1990
transaction.  As a part  of the consideration  for the June  1992 agreement, the
Company agreed to assume BMA's  former responsibility for future obligations  to
W. D. Grant under his supplemental retirement agreement. The annual amount owing
to  Mr. Grant  under such  agreement is  approximately $130,000,  payable to Mr.
Grant until death, and  thereafter at a  reduced level to  his spouse until  her
death.

    In July 1992 the Company loaned William H. West, M.D., Chairman of the Board
and Chief Executive Officer of the Company's majority-owned subsidiary, Response
Technologies,  Inc. ("Response"),  $500,000. Principal and  accrued interest, at
the rate of 6.74%, are due on the fourth anniversary of the loan. As of December
31, 1994, accrued  interest on the  loan was  $86,917. Payment of  said loan  is
secured by a pledge of 130,333 shares of Response common stock.

    In  1994  P.  Anthony  Jacobs  and his  wife  purchased  from  the Company's
wholly-owned real estate subsidiary, Scout Development Corporation ("Scout"),  a
condominium  unit at  Scout's Quail  Run project  in Santa  Fe, New  Mexico. The
purchase price  was  approximately  $620,000.  The  Company  believes  that  the
purchase  price and  the other terms  of the transaction  were substantially the
same as  would  have existed  with  an  unaffiliated buyer,  provided  that  the
Company's  long-standing agreement with the real estate agents for the Quail Run
project excludes  units sold  to officers  or employees  of the  Company or  its
affiliates  from  the Company's  real estate  commission obligations,  and these
savings (approximately $33,000) were passed on  to Mr. and Mrs. Jacobs  pursuant
to Company policy applicable to all corporate officers.

    In  September 1994 LabONE, Inc., the  Company's 82% owned subsidiary, loaned
Bert H. Hood, LabONE's Chairman and Chief Executive Officer, $150,000 to  assist
him with the payment of certain personal expenses. Interest at the rate of 7.75%
per  annum is due  quarterly and the principal  of the loan is  due on the first
anniversary of the loan, in September  1995, or sooner if Mr. Hood's  employment
with  LabONE terminates. Interest payments are  current and the entire principal
balance of the loan was outstanding as of March 31, 1995.

SECURITY OWNERSHIP OF MANAGEMENT

    The following table and notes thereto indicate the shares of Company  Common
Stock  and of  the common  stock of  the Company's  majority-owned subsidiaries,
LabONE, Inc. ("LabONE") and  Response Technologies, Inc.  ("RTK"), known to  the
Company    to   be   beneficially   owned   as   of   February   1,   1995,   by

                                       7
<PAGE>
each director (including the nominees for election as directors) of the Company,
each of the executive officers named in the Summary Compensation Table beginning
on page 11,  and by all  directors and executive  officers of the  Company as  a
group.

<TABLE>
<CAPTION>
                                                                  SHARES OF COMMON
                         SHARES OF COMPANY                        STOCK OF LABONE     SHARES OF COMMON
                            COMMON STOCK                            BENEFICIALLY        STOCK OF RTK
                         BENEFICIALLY OWNED     PERCENTAGE OF          OWNED         BENEFICIALLY OWNED
NAME                         (1)(2)(13)           CLASS (14)        (1)(15)(16)         (1)(19)(20)
- ----------------------  --------------------   ----------------   ----------------   ------------------

<S>                     <C>                    <C>                <C>                <C>
Lan C. Bentsen........              22,541(3)         --                -0-                 -0-
John C. Gamble........             125,142(4)              1.9%         -0-                 -0-
W. D. Grant...........           1,296,115(5)             20.2%           34,189            -0-
W. T. Grant II........             277,658(6)              4.2%           29,231               19,000
Michael E. Herman.....              28,081(7)         --                   6,217(17)           11,000
Bert H. Hood..........                 -0-(8)         --                 200,206(18)        -0-
P. Anthony Jacobs.....             139,798(9)              2.1%           21,843               39,000
David W. Kemper.......              17,118(10)        --                -0-                 -0-
John H. Robinson,
 Jr...................              18,714            --                -0-                 -0-
James R. Seward.......              82,351(11)             1.3%         -0-                    39,000
Dennis R. Stephen.....               5,792            --                -0-                 -0-
William H. West,
 M.D..................                 -0-(8)         --                -0-                 3,701,300
All directors,
 nominees and
 executive officers as
 a group (13
 persons).............           1,987,932(12)            29.2%          269,618            3,809,300
<FN>
- ------------------------

 (1) A  beneficial  owner  of a  security  includes  a person  who,  directly or
     indirectly, has or shares voting or  investment power with respect to  such
     security.  Voting power is  the power to  vote or direct  the voting of the
     security and  investment  power is  the  power  to dispose  or  direct  the
     disposition  of the security. Each person listed has stated that he, either
     alone or with his spouse, has  sole voting power and sole investment  power
     with respect to the shares shown as beneficially owned, except as otherwise
     indicated.

 (2) Shares  of Company Common Stock shown  as beneficially owned include shares
     issuable upon the  exercise of  stock options granted  under the  Company's
     1984,  1989 and 1991 Stock Option and Incentive Plans that were exercisable
     on February 1, 1995 or that  became exercisable within 60 days  thereafter,
     as  follows: Lan C. Bentsen, 15,000  shares; John C. Gamble, 15,000 shares;
     W. D.  Grant, 5,000  shares; W.  T. Grant  II, 146,492  shares; Michael  E.
     Herman,  15,000 shares; P. Anthony Jacobs, 105,500 shares; David W. Kemper,
     10,000 shares;  John H.  Robinson,  Jr., 15,000  shares; James  R.  Seward,
     46,667 shares; and all directors and executive officers as a group, 388,659
     shares.

 (3) Includes  6,860  shares held  by  a family  trust  for the  benefit  of Mr.
     Bentsen's children,  as  to which  he  disclaims beneficial  ownership.  An
     unaffiliated person is trustee with sole voting and investment powers.

 (4) Includes  41,182 shares owned by Mr. Gamble's wife and 7,939 shares held by
     his wife as custodian for her children,  45,000 shares held in a trust  for
     which  his  wife serves  as co-trustee  with W.  T. Grant  II, and  in that
     capacity shares voting and investment powers, and 11,562 shares held by his
     wife's son.  Mr. Gamble  disclaims beneficial  ownership of  the  foregoing
     shares owned by his wife or her son or over which she has trust powers.

 (5) Includes 237,960 shares held by a family trust for which W. D. Grant serves
     as  a co-trustee, and in that  capacity shares voting and investment powers
     (during 1994  and prior  years  the other  co-trustee was  Boatmen's  First
     National   Bank  of  Kansas  City);  includes   39,517  shares  held  by  a
</TABLE>

                                       8
<PAGE>
<TABLE>
<S>  <C>
     family foundation of which W. D. Grant shares voting and investment  powers
     with United Missouri Bank of Kansas City, N.A.; also includes 26,850 shares
     owned  by the  wife of  W. D.  Grant, as  to which  he disclaims beneficial
     ownership.

 (6) Includes 29,296  shares  held  by W.  T.  Grant  II as  custodian  for  his
     children;  includes 45,000 shares  held in a  family trust for  which W. T.
     Grant II serves  as a  co-trustee with Laura  Gamble and  in that  capacity
     shares  voting and investment powers; also  includes 11,298 shares owned by
     the wife of W. T. Grant II, as to which he disclaims beneficial ownership.

 (7) Includes 400 shares owned  by Mr. Herman's wife,  as to which he  disclaims
     beneficial  ownership; 11,356 shares are owned by the Herman Family Trading
     Company of which  Mr. Herman  is a  general partner  and approximately  73%
     owner.

 (8) Mr.  Hood and Dr.  West are, respectively, the  Chief Executive Officers of
     the Company's  majority-owned  subsidiaries, LabONE,  Inc.  ("LabONE")  and
     Response  Technologies, Inc.  ("RTK"); neither  is a  director or corporate
     officer of the Company.

 (9) Includes 1,000 shares owned by the wife and 200 shares owned by the son  of
     P. Anthony Jacobs as to which he disclaims beneficial ownership.

(10) Includes 5,646 shares held in a family trust for which Mr. Kemper serves as
     a trustee, and in that capacity shares voting power and has sole investment
     power.

(11) Includes 1,500 shares held in a family trust for which Mr. Seward serves as
     a  co-trustee  with his  mother,  and in  that  capacity shares  voting and
     investment powers.

(12) Includes (i)  388,659 shares  of  Company Common  Stock issuable  upon  the
     exercise  of  stock options  granted under  the 1984,  1989 and  1991 Stock
     Option and Incentive  Plans that were  exercisable on February  1, 1995  or
     that  became exercisable within 60 days thereafter and (ii) an aggregate of
     9,703 shares held under  the Seafield Capital  Corporation 401(k) Plan  and
     Trust  (based upon the  Plan statement as  of December 31,  1994) which are
     held in  a trust  of which  The  Investors Services  Trust Company  is  the
     trustee, but as to which the trustee is obligated to grant voting rights to
     the  Plan Administrative  Committee, comprising  executive officers  of the
     Company, if requested by said Committee.

(13) Includes as to each of the following individuals, the following numbers  of
     shares  held  in  their  respective  accounts  under  the  Seafield Capital
     Corporation 401(k) Plan and Trust as of December 31, 1994 (based on a  plan
     statement  of  that  date),  as  to  which  shares  the  individual  shares
     investment power but, except  in the case of  Mr. Seward who shares  voting
     power  as to all 9,703 shares held in the 401(k) Plan, does not have voting
     power; W. T.  Grant II,  991 shares; P.  Anthony Jacobs,  1,211 shares  and
     James R. Seward, 628 shares (plus an additional 9,075 shares as to which he
     shares  voting  power  as  a  member  of  the  401(k)  Plan  Administrative
     Committee).

(14) The percentages represent the total number of shares of Common Stock  shown
     in  the adjacent  column divided  by the  number of  issued and outstanding
     shares of Common Stock as of February 1, 1995 (6,415,854 shares), plus,  in
     each  instance, all shares of Common Stock  issuable to the person or group
     named upon the exercise of stock options granted under the Company's  1984,
     1989  and 1991 Stock Option Plans that were exercisable on February 1, 1995
     or that became exercisable within  60 days thereafter. Percentages of  less
     than one percent are omitted.

(15) Shares  of LabONE stock shown as beneficially owned include shares issuable
     upon the  exercise of  stock  options granted  under the  LabONE  Long-Term
     Incentive  Plan that  were exercisable on  February 1, 1995  or that became
     exercisable within  60 days  thereafter, as  follows: W.  D. Grant,  20,372
     shares;  W. T.  Grant II, 27,431  shares; Michael E.  Herman, 4,400 shares;
     Bert H. Hood,  200,000 shares; P.  Anthony Jacobs, 20,343  shares; and  all
     directors and executive officers as a group, 272,546.
</TABLE>

                                       9
<PAGE>
<TABLE>
<S>  <C>
(16) Percentages of shares beneficially owned are less than 1% for all directors
     and  executive officers individually; the  shares beneficially owned by all
     directors and  executive  officers  as  a  group  constitute  2.2%  of  the
     aggregate  of the number  of LabONE shares outstanding  at February 1, 1995
     (13,043,872), plus the number of shares  of LabONE stock issuable upon  the
     exercise  of  stock  options  held  by  members  of  the  group  which were
     exercisable on February 1, 1995 or  that became exercisable within 60  days
     thereafter.

(17) Includes  1,817 shares owned by the  Herman Family Trading Company of which
     Mr. Herman is a general partner and approximately 73% owner.

(18) Includes 206 shares held in  an account for the  benefit of Mr. Hood  under
     LabONE's  401(K) Profit  Sharing Plan, as  to which he  has sole investment
     power only.

(19) Percentages of shares beneficially owned are less than 1% for all directors
     and executive officers, except that William H. West, M.D. beneficially owns
     10.3% and all directors and executive officers as a group beneficially  own
     10.6%  of the number of RTK shares  of common stock outstanding at February
     1, 1995  (34,822,172),  plus the  number  of  shares of  RTK  common  stock
     issuable upon the exercise of stock options or warrants held by Dr. West or
     members  of  the group,  as  the case  may  be, which  were  exercisable on
     February 1, 1995 or that became exercisable within 60 days thereafter.

(20) Shares of  RTK common  stock  shown as  beneficially owned  include  shares
     issuable  upon the  exercise of  RTK stock  options and  warrants that were
     exercisable on February 1, 1995 or  that became exercisable within 60  days
     thereafter  as follows: W.  T. Grant II, 17,000  shares; P. Anthony Jacobs,
     17,000 shares;  James R.  Seward,  17,000 shares;  William H.  West,  M.D.,
     1,091,400  shares; and  all directors  and executive  officers as  a group,
     1,142,400 shares.
</TABLE>

COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT

    The Company believes that  its officers and  directors have timely  reported
all 1994 transactions in Company Common Stock required to be reported by Section
16(a) of the Securities Exchange Act of 1934.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS

    The   following  table  indicates   the  shares  of   Company  Common  Stock
beneficially owned by  the only  persons (other than  persons set  forth in  the
preceding  table) known to the Company  or its management as beneficially owning
more than five percent of the Company's Common Stock as of January 1, 1995.

<TABLE>
<CAPTION>
                                                             AMOUNT AND NATURE                PERCENT OF
    NAME AND ADDRESS OF BENEFICIAL OWNER                  OF BENEFICIAL OWNERSHIP              CLASS (1)
- ---------------------------------------------  ---------------------------------------------  -----------
<S>                                            <C>                                            <C>
Boatmen's Bancshares, Inc.                     Total -- 437,620(2)                                  6.9%
One Boatmen's Plaza                                sole voting power -- 166,557                     2.6%
St. Louis, Missouri 63101                          shared voting power -- 248,563                   3.9%
                                                   sole disposition power -- 0                       -0-
                                                   shared disposition power -- 396,720              6.2%
<FN>
- ------------------------
(1)  The percentage represents the total numbers of shares of Common Stock shown
     in the adjacent  column divided  by the  number of  issued and  outstanding
     shares of Common Stock as of February 1, 1995.

(2)  As  reported in a Schedule 13G filing  as of December 31, 1994. This amount
     includes 395,369 shares beneficially owned by Boatmen's First National Bank
     of Kansas  City, Kansas  City, Missouri  64183, a  subsidiary of  Boatmen's
     Bancshares,  Inc.,  as to  237,960  shares of  which  it shared  voting and
     investment powers with W. D. Grant.  Mr. Grant, a director of the  Company,
     is  also  a  director of  Boatmen's  First  National Bank  of  Kansas City.
     Pursuant to an amended Schedule 13G,
</TABLE>

                                       10
<PAGE>
<TABLE>
<S>  <C>
     dated March 6,  1995, Boatmen's  Bancshares, Inc.  reported its  beneficial
     ownership had declined
     to 3%; this decrease reflects a change in co-trustee of the trust for which
     Mr.  W. D. Grant serves,  and Boatmen's First National  Bank of Kansas City
     formerly served, as co-trustees.
</TABLE>

COMPENSATION OF EXECUTIVE OFFICERS

    The following table sets forth compensation received by the Company's  Chief
Executive  Officer and the four most  highly paid executive officers, other than
the Chief Executive Officer, holding office  at December 31, 1994, for  services
rendered  in all  capacities to  the Company and  its subsidiaries  for the last
three years.

                           SUMMARY COMPENSATION TABLE

<TABLE>
<CAPTION>
                                                                    AWARDS         PAYOUTS
                                                                 -------------  -------------
                                                                    LONG-TERM COMPENSATION
                                                                 ----------------------------
                                                                  SECURITIES
                                       ANNUAL COMPENSATION (1)    UNDERLYING
NAME AND PRINCIPAL                     ------------------------  OPTIONS/SARS   LTIP PAYOUTS        ALL OTHER
POSITION                      YEAR     SALARY ($)   BONUS ($)(2)      (#)          ($)(8)      COMPENSATION ($)(9)
- --------------------------  ---------  -----------  -----------  -------------  -------------  -------------------
<S>                         <C>        <C>          <C>          <C>            <C>            <C>
W. T. Grant II                   1994  $   320,000      -0-            16,000(6)      -0-          $    24,689
 Chairman of the Board and       1993      320,000      -0-           -0-       $   1,168,000           34,597
 Chief Executive Officer         1992      320,000      -0-           -0-             498,000           31,956
 of the Company

P. Anthony Jacobs                1994      238,825      -0-            16,000(6)      -0-               39,557
 President and Chief             1993      231,167      -0-           -0-             730,000           49,408
 Operating Officer of the        1992      217,417      -0-           -0-             311,250           41,559
 Company

James R. Seward                  1994      140,938      -0-            16,000(6)      -0-               21,106
 Executive Vice President        1993      136,417   $  10,000        -0-             562,100           17,485
 and Chief Financial             1992      127,500      -0-           -0-             217,875           17,558
 Officer of the Company

Bert H. Hood                     1994      200,641      -0-           -0-            -0-                20,075
 Chairman of the Board,          1993       83,333(3)    100,000      200,000(7)      -0-               76,849(10)
 President and Chief             1992      -0-          -0-           -0-            -0-               -0-
 Executive Officer of
 LabONE, Inc.(4)

William H. West, M.D.            1994      185,000      -0-           -0-            -0-                   137
 Chairman of the Board and       1993      185,000      -0-           368,000(6)      -0-                  102
 Chief Executive Officer         1992      165,475      50,000        275,000(6)      -0-                  127
 of Response Technologies,
 Inc.(5)
<FN>
- ------------------------
(1)  Compensation deferred at the election of an executive officer, pursuant  to
     the  Company's or its  subsidiaries' 401(k) Plans, is  included in the year
     earned.

(2)  The Company discontinued  its cash bonus  program in 1991  and replaced  it
     with  Restricted  Stock  Awards  (see  footnote  8  below).  The  Company's
     Compensation Committee and Board of Directors retained, however,  authority
     to  make  discretionary  bonus  awards  in  special  circumstances;  it was
     pursuant to that authority that a 1993 bonus was awarded to Mr. Seward. The
     Company's
</TABLE>

                                       11
<PAGE>
<TABLE>
<S>  <C>
     subsidiaries which employ Mr. Hood and Dr. West continue to have cash bonus
     programs; howev-
     er, no  cash bonuses  were  awarded to  those  individuals for  1994.  Cash
     bonuses for services rendered in 1993 and 1992 have been listed in the year
     earned; in some cases they were actually paid in the following year. In the
     case  of Mr. Hood and Dr. West, bonuses  were paid by the company with whom
     the individual is employed based upon said company's operating results  and
     the performance of the individual.

(3)  Mr. Hood's employment with LabONE, Inc. began in August 1993.

(4)  LabONE, Inc. is 82% owned by the Company.

(5)  Response Technologies, Inc. is 59% owned by the Company.

(6)  Consists entirely of options to purchase shares of common stock of Response
     Technologies, Inc. Of the options shown in the table as granted to Dr. West
     in  1993, 268,000 were options granted in  1992 (and are part of the number
     reported for 1992) and repriced in 1993.

(7)  Consists entirely of options to purchase shares of common stock of  LabONE,
     Inc.

(8)  Represents  the dollar value  of shares of Company  Common Stock granted as
     Restricted Stock Awards under the Company's 1989 Stock Option and Incentive
     Plan, which became  performance vested  in the  year indicated.  Restricted
     Stock  Awards were made in 1991 to  replace the Company's annual cash bonus
     program which was discontinued in that year. After Restricted Stock becomes
     performance vested, it time  vests, generally, in equal  parts on the  1st,
     2nd  and  3rd  anniversaries  of the  date  of  performance  vesting. Thus,
     generally, the Restricted Stock which performance vests in a given year  is
     not available to the grantee in that year. While SEC rules require the full
     value  of performance vested Restricted  Stock to be shown  for the year in
     which performance vesting occurs, the  benefit of said Restricted Stock  is
     not  available  to  the  grantee  until  full  time  vesting  occurs, which
     generally is in subsequent  years (i.e., 1/3 per  year over the  succeeding
     three  years). The  value of  Restricted Stock  which fully  time vested in
     1994, 1993 and 1992 (valued at the  date of full time vesting) for each  of
     the named executives was:
</TABLE>

<TABLE>
<CAPTION>
  EXECUTIVE OFFICER       1994        1993        1992
- ---------------------  -----------  ---------  -----------
<S>                    <C>          <C>        <C>
W. T. Grant II         $   657,310  $  94,012  $   251,636
P. Anthony Jacobs          410,810     58,762      157,261
James R. Seward            239,555     30,562      101,261
<FN>

     No  dividends (or  payments in lieu  thereof) are paid  on Restricted Stock
     until  all  restrictions  lapse  (including  holding  period   restrictions
     following   performance  vesting).   See  "Report   of  The   Directors  --
     Compensation Committee on Executive Compensation"  for a discussion of  the
     Restricted  Stock Awards. All shares of Restricted Stock held by any of the
     named executive officers had performance vested by December 31, 1993,  with
     the  value of such  shares at the  time of performance  vesting in 1993 and
     1992 being shown in the Table as an "LTIP Payout" for 1993 or 1992, as  the
     case  may be. Some of  these shares had not time  vested and, thus, had not
     been
</TABLE>

                                       12
<PAGE>
<TABLE>
<S>  <C>
     issued to the named executive officers as of December 31, 1994. The  number
     and December 31,
     1994  value of  shares of  Restricted Stock  owned by  each named executive
     officer which had not time vested as of such date were as follows:
</TABLE>

<TABLE>
<CAPTION>
                       NON-TIME VESTED SHARES  VALUE AT DECEMBER
        NAME            OF RESTRICTED STOCK        31, 1994
- ---------------------  ----------------------  -----------------
<S>                    <C>                     <C>
W. T. Grant II                   26,668           $   913,379
P. Anthony Jacobs                16,668               570,879
James R. Seward                  12,601               431,584
<FN>

(9)  Includes  the  following  contributions  paid  or  accrued  to  the   named
     executive's  accounts in the Company's, or one of its subsidiaries', as the
     case may  be,  401(k)  Plan  ("401(k)") and  Money  Purchase  Pension  Plan
     ("MPP"), pursuant to a Supplemental Retirement Agreement ("SERP") with said
     executive and for term life insurance for said executive:
</TABLE>

<TABLE>
<CAPTION>
                                                                                            TERM LIFE INS.
                    401(K)                     MPP                      SERP                   PREMIUMS
            ----------------------  -------------------------  -----------------------  ----------------------
EXECUTIVE    1994    1993    1992    1994     1993     1992     1994    1993     1992    1994    1993    1992
- ----------  ------  ------  ------  -------  -------  -------  ------  -------  ------  ------  ------  ------
<S>         <C>     <C>     <C>     <C>      <C>      <C>      <C>     <C>      <C>     <C>     <C>     <C>
WTG.......  $4,620  $4,497  $6,885  $15,596  $16,509  $16,230  $2,453  $11,571  $6,955  $2,020  $2,020  $1,886
PAJ.......   4,620   4,497   4,479   15,596   16,509   16,793  17,836   26,945  19,071   1,505   1,457   1,216
JRS.......   4,620   4,497   5,556   15,596   12,126   11,250   -0-      -0-     -0-       890     862     752
BHH.......   4,620   -0-     -0-     15,455    -0-      -0-     -0-      -0-     -0-     -0-     -0-     -0-
WHW.......   -0-     -0-     -0-      -0-      -0-      -0-     -0-      -0-     -0-       137     102     127
<FN>

The initials above are the initials for the following executive officers: WTG --
W.  Thomas Grant II;  PAJ -- P. Anthony  Jacobs; JRS -- James  R. Seward; BHH --
Bert H. Hood; and WHW -- William H. West, M.D.

(10) Includes a $60,000 signing bonus paid to Mr. Hood upon the execution of his
     Employment Agreement  with  LabONE, Inc.  in  August 1993  and  $16,849  in
     relocation  expenses in connection with his  move from Dallas, Texas to the
     Kansas City area.
</TABLE>

                       OPTION GRANTS IN LAST FISCAL YEAR

    No Company options were  granted in 1994 to  any executive officer shown  in
the  Summary  Compensation Table.  The  following table  sets  forth information
respecting options granted  in 1994  by Response Technologies,  Inc. ("RTK"),  a
59%-owned  subsidiary  of the  Company, to  Company  corporate officers  who are
members of  the  Board of  Directors  of RTK.  All  such options  are  presently
exercisable.  All such options  are non-statutory options,  receiving no special
tax benefits, and have a term of ten years. All such options are entitled to the
benefit of cashless exercise provisions of the RTK option plan pursuant to which
they were  issued. None  of the  option  grants in  1994 included  tandem  SARs,
performance  units  or other  instruments, or  any  reload or  tax reimbursement
features.

                                       13
<PAGE>

<TABLE>
<CAPTION>
                                                                                            POTENTIAL REALIZABLE
                                                   INDIVIDUAL GRANTS                          VALUE AT ASSUMED
                             -------------------------------------------------------------    ANNUAL RATES OF
                              NUMBER OF    PERCENT OF                 GRANT                     STOCK PRICE
                             SECURITIES   TOTAL OPTIONS  EXERCISE     DATE                    APPRECIATION FOR
                             UNDERLYING    GRANTED IN     OR BASE    MARKET                    OPTION TERM(2)
                               OPTIONS       FISCAL        PRICE      PRICE    EXPIRATION   --------------------
NAME                         GRANTED(#)      YEAR(1)      ($/SH)     ($/SH)       DATE        5%($)     10%($)
- ---------------------------  -----------  -------------  ---------  ---------  -----------  ---------  ---------
<S>                          <C>          <C>            <C>        <C>        <C>          <C>        <C>
W. Thomas Grant II                1,000         .17 %    $ 2.6875   $  2.6875     10/1/04   $   1,690  $   4,283
                                 15,000        2.55 %      2.00        2.8125     12/2/04      38,719     79,424
P. Anthony Jacobs                 1,000         .17 %      2.6875      2.6875     10/1/04   $   1,690  $   4,283
                                 15,000        2.55 %      2.00        2.8125     12/2/04      38,719     79,424
James R. Seward                   1,000         .17 %      2.6875      2.6875     10/1/04   $   1,690  $   4,283
                                 15,000        2.55 %      2.00        2.8125     12/2/04      38,719     79,424
Bert H. Hood                     -0-           N/A          N/A        N/A        N/A
William H. West, M.D.           -0-           N/A           N/A        N/A        N/A
<FN>
- ------------------------
(1)  Represents the percentages of options granted by RTK in 1994.

(2)  The dollar amounts under  these columns are the  result of calculations  at
     the  5% and  10% rates set  by SEC rules  and are not  intended to forecast
     possible future appreciation, if any, in RTK's stock price.
</TABLE>

                AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR
                           AND YEAR-END OPTION VALUES

    The following table provides information on option exercises in 1994 by  the
named executive officers and the values of such officers' unexercised options at
December  31, 1994.  Except as  noted, the  information pertains  to options for
Company Common Stock.

<TABLE>
<CAPTION>
                                                              NUMBER OF SECURITIES
                                                             UNDERLYING UNEXERCISED         VALUE OF UNEXERCISED
                                                                     OPTIONS                IN-THE-MONEY OPTIONS
                              SHARES                             AT YEAR-END (#)             AT YEAR-END ($)(3)
                            ACQUIRED ON        VALUE       ---------------------------   ---------------------------
          NAME             EXERCISE (#)     REALIZED ($)   EXERCISABLE   UNEXERCISABLE   EXERCISABLE   UNEXERCISABLE
- ------------------------  ---------------   ------------   -----------   -------------   -----------   -------------
<S>                       <C>               <C>            <C>           <C>             <C>           <C>
W. T. Grant II                -0-              -0-           146,492        -0-           $  853,966       $-0-
                                                              21,944(1)       5,487(1)       123,435(1)     30,864(1)
                                                              16,000(2)     -0-              -0-          -0-
P. Anthony Jacobs             -0-              -0-           105,500        -0-              676,063      -0-
                                                              15,943(1)       6,057(1)        83,466(1)     29,928(1)
                                                              16,000(2)     -0-              -0-          -0-
James R. Seward               -0-              -0-            46,667        -0-              269,267      -0-
                                                              16,000(2)     -0-              -0-          -0-
Bert H. Hood                  -0-              -0-           150,000(1)      50,000(1)       168,750(1)     56,250(1)
William H. West, M.D.         -0-              -0-           401,400(2)     223,600(2)       240,675(2)    -0-
<FN>
- ------------------------
(1)  Consists entirely of options to purchase shares of common stock of  LabONE,
     Inc.  ("LabONE") and the value (i.e.  market value of underlying securities
     minus option exercise price) at December 31, 1994 of such options.

(2)  Consists entirely of options to purchase shares of common stock of Response
     Technologies, Inc. ("RTK") and the  value (i.e. market value of  underlying
     securities  minus  option  exercise price)  at  December 31,  1994  of such
     options.

(3)  The closing price on December 31, 1994 of Company Common Stock was  $34.25;
     of LabONE common stock was $15.50; and of RTK common stock was $1.6875.
</TABLE>

                                       14
<PAGE>
EMPLOYMENT AGREEMENTS; TERMINATION OF EMPLOYMENT AND CHANGE-OF-CONTROL
COMPENSATION ARRANGEMENTS

    THE  COMPANY --  CHANGE-OF-CONTROL.   The Company  has entered  into certain
Termination Compensation  Agreements with  Messrs. W.  T. Grant  II, P.  Anthony
Jacobs  and James R. Seward. Under the Termination Compensation Agreements, each
such officer could  receive, in  the event his  employment with  the Company  is
terminated  by the Company (for a reason  other than death, normal retirement or
permanent disability) or is terminated by him for good cause, within three years
following a change-of-control  of the Company,  a lump sum  payment up to  three
times the officer's average annual gross income for the five tax years preceding
the year of termination.

    A   "change-of-control"  under   the  Termination   Compensation  Agreements
generally is deemed to have occurred if, as the result of (i) a tender offer  or
other  acquisition  of securities  of the  Company any  person, entity  or group
becomes the  beneficial owner,  directly  or indirectly,  of securities  of  the
Company  representing 25%  or more  of the  voting power  of outstanding Company
securities, or (ii) a  contested election of directors,  either the persons  who
were  directors of the  Company immediately prior thereto,  or new persons whose
nomination was approved  by two-thirds  of the directors  in office  immediately
prior thereto, cease to constitute a majority of the Board of Directors.

    Had  a "change-of-control" taken  place on December  31, 1994, the following
executive officers identified in the Summary Compensation Table would have  been
entitled to receive, had their employment ceased on that date, lump sum payments
in  the following amounts under their Termination Compensation Agreements: W. T.
Grant II -- $2,089,125; P. Anthony Jacobs -- $1,208,243; and James R. Seward  --
$763,085.

    All  unvested  restricted  stock  awards vest  if  events  similar  to those
described as a "change-of-control" above shall occur.

    SUBSIDIARIES --  EMPLOYMENT  AGREEMENTS; CHANGE-OF-CONTROL.    LabONE,  Inc.
("LabONE")  has an employment  agreement with Bert H.  Hood, its Chief Executive
Officer, who  is  an executive  officer  of the  Company  named in  the  Summary
Compensation  Table. The Agreement provides for the employment of Mr. Hood for a
three-year term  ending  in  1996  and  is  renewable  annually  thereafter  for
successive  one-year terms unless LabONE elects not to extend the Agreement. Mr.
Hood's compensation under the Agreement consists of a signing bonus of  $60,000,
an annual base salary of not less than $200,000, an annual incentive bonus to be
established by LabONE's Compensation Committee after consultation with Mr. Hood,
the purchase by LabONE of Mr. Hood's Texas residence for a purchase price net to
Mr.  Hood  equal to  the  average of  the fair  market  values of  the residence
established by two independent appraisers, the granting of a non-qualified stock
option to Mr. Hood for 200,000 shares of LabONE common stock, and  participation
in  LabONE's other  fringe benefit  programs for  executives. In  the event that
LabONE terminates  Mr.  Hood's  employment  without cause  (as  defined  in  the
Agreement),  LabONE will pay to  Mr. Hood a lump  sum severance payment equal to
his base salary  due for  the balance  of the term  of the  Agreement, plus  one
year's  annual base salary. If a change-of-control  of LabONE (as defined in the
Agreement)  occurs  at  any  time  while  Mr.  Hood  is  in  LabONE's  full-time
employment,  and  within one  year after  such a  change-of- control  Mr. Hood's
employment is terminated for any  reason other than permanent disability,  death
or  normal retirement,  LabONE will pay  Mr. Hood as  termination compensation a
lump sum amount  equal to three  times his average  annual compensation for  the
most recent five taxable years (subject to certain limitations prescribed in the
Internal  Revenue  Code)  and  any  remaining term  of  the  Agreement  shall be
canceled. Under the Agreement, Mr. Hood agrees not to compete with LabONE for  a
period of two years after the termination of his employment with LabONE.

    The  stock options granted under the  LabONE Long-Term Incentive Plan to Mr.
Hood provide that the options  held by him shall  become fully exercisable if  a
change-of-control  of LabONE  (as defined in  the stock  option agreement) shall
occur, or  upon  termination of  his  employment  by LabONE  without  cause  (as
defined).

                                       15
<PAGE>
    Had  a "change-of-control" (as defined in LabONE's employment agreement with
Mr. Hood) taken place on December 31, 1994, Mr. Hood would have been entitled to
receive, had his employment ceased  on that date, a  lump sum payment under  his
employment agreement in the amount of $875,649.

    Response  Technologies, Inc.  ("RTK") had  an employment  agreement with Dr.
William H. West, its Chief Executive Officer, who is an executive officer of the
Company named  in the  Summary Compensation  Table, which  expired December  31,
1994, providing for a minimum base salary of $150,000 per year. RTK and Dr. West
are  in the process of negotiating a new employment agreement; it is expected to
provide for an initial base salary of $192,400 per year, subject to review  each
year  but with a condition that the base  salary may not be reduced by more than
5% in any one year. It is  anticipated that Dr. West's new employment  agreement
will  contain  provisions  providing for  severance  payments in  the  event his
employment is terminated without  cause or by reason  of a change-of-control  of
RTK. The severance amounts have not yet been agreed to, but they are expected to
be  no less than  the amounts provided  for in the  expired agreement. Under the
expired agreement, Dr. West was entitled to a severance payment equal to 150% of
his then current  base salary if  his employment was  terminated without  cause,
whether or not in connection with a change-of-control. In the expired agreement,
Dr.  West agreed to  refrain from disclosing any  information respecting RTK, to
refrain from competing with RTK  during the term of  his employment and for  two
years  thereafter, and to refrain from hiring or soliciting employees or clients
of RTK for two years after his employment terminates. It is anticipated that the
new agreement will contain similar provisions, although perhaps for not as  long
a period.

    OTHER  ARRANGEMENTS.   In 1991 the  Company's Board of  Directors approved a
Supplemental Retirement Agreement with Mr. Jacobs  pursuant to which he will  be
entitled  to  either  a  lump sum  payment  or  actuarially  equivalent periodic
payments upon or commencing, respectively, with  his retirement at or after  age
55  or his earlier  death, disability or  involuntary termination of employment.
The amount of  the lump  sum payment  is to be  determined by  assuming (i)  the
hypothetical  deposit  into  a  fund  of $12,000  on  January  1  of  each year,
commencing with 1991 and ending on the date of his retirement, death, disability
or involuntary termination, and (ii) that amounts deposited earn interest at  9%
per  annum. The amount payable  to Mr. Jacobs under  the agreement, assuming his
retirement at age 65, would be $443,700.

           REPORT OF THE BOARD OF DIRECTORS -- COMPENSATION COMMITTEE
                           ON EXECUTIVE COMPENSATION

    Set forth below under the subheading "The Company -- Executive Compensation"
is the report  of the  Nominating and  Compensation Committee  of the  Company's
Board  of Directors on Executive Compensation. The only executive officers shown
in the Summary Compensation Table, commencing on page 11, to which this report's
discussion of  compensation  policies  is applicable  are  the  Company's  Chief
Executive  Officer and Messrs.  Jacobs and Seward;  the other executive officers
listed in  the  Summary Compensation  Table  are corporate  officers  of  public
company  subsidiaries  of the  Company  and are  not  corporate officers  of the
Company. The Nominating  and Compensation  Committee of the  Company's Board  of
Directors  does  not have  responsibility  for and  in  fact does  not establish
compensation policy for officers of  those subsidiaries; the Board of  Directors
of  each  subsidiary  has  its  own  compensation  committee,  which establishes
compensation policies for the executive officers of that subsidiary.

    Under   the   subheading   below   entitled   "Subsidiaries   --   Executive
Compensation," there is a discussion of the compensation policies established by
the  Compensation Committee of LabONE, Inc.'s Board of Directors respecting Bert
H. Hood, its Chief Executive Officer, an executive officer of the Company  named
in  the Summary Compensation Table, and the compensation policies established by
the Compensation Committee of Response  Technologies, Inc.'s Board of  Directors
respecting  William H. West,  M.D., its Chief  Executive Officer and  one of the
Company's executive officers named in the Summary Compensation Table.

                                       16
<PAGE>
    The discussion  of compensation  policies respecting  corporate officers  of
subsidiaries of the Company is made over the names of the Company's entire Board
of  Directors. It constitutes a summary of the reports of executive compensation
submitted to the Company's Board of Directors by the Compensation Committees  of
those  subsidiaries. The Company's  Board of Directors has  taken no action with
respect to these reports, nor has it participated in the preparation thereof.

                     THE COMPANY -- EXECUTIVE COMPENSATION

    The  Company's  executive  compensation  program  is  administered  by   the
Nominating  and Compensation Committee of the  Board of Directors. The Committee
is composed of six Non-Employee Directors. Following review and approval by  the
Nominating  and  Compensation  Committee,  all  issues  pertaining  to executive
compensation are reported  to the  Board of  Directors, and,  except for  awards
under the Company's stock based compensation plans, are approved by the Board of
Directors.

COMPENSATION POLICIES

    GENERAL.  Following the 1990 sale of its life and health insurance business,
the  Company had a diverse group of assets consisting of a significant amount of
cash, a  holdover portfolio  of  direct real  estate investments,  interests  in
several  venture capital investments,  and a majority  ownership of LabONE, Inc.
("LabONE"), whose  principal business  is laboratory  testing services  for  the
insurance  industry.  The Board  of  Directors determined  that  the appropriate
strategy  for  the  newly  structured  holding  company  would  be  to  increase
shareholder  value by deploying  its cash in  developing businesses that provide
services to the insurance and health care industries while liquidating its  real
estate  portfolio and other assets that  were not consistent with this strategic
focus.

    As a result  of this  dramatic shift in  the environment  for the  Company's
management  from operating  in the  mature and  regulated insurance  industry to
investing as  a holding  company  in early  stage  businesses with  high  growth
potential,  and  correspondingly  higher  business  risks,  the  Nominating  and
Compensation Committee initiated the design of an executive compensation  system
which  would reward behavior  that reinforced the new  direction of the Company.
The Committee concluded that this system should emphasize long-term  performance
in  support of  the Company's  long-term objectives.  The resulting equity-based
compensation program is  tied to  long-term increases in  shareholder value,  as
measured  by the price  of Company Common  Stock, and not  to annual earnings or
other short-term measures of performance. The annual cash incentive program  was
discontinued  in 1991; the current executive compensation structure has only two
elements -- base salary and a long-term, stock-based compensation component.

    BASE SALARY  COMPENSATION.   The  Committee's policy  is to  establish  base
salaries  for  each of  the Company's  executive  officers at  approximately the
median  of  salaries  for  comparable  positions  at  non-manufacturing  general
industrial and financial services companies. In 1994, executive officer salaries
were  based  upon  a  1990  survey of  such  comparable  positions  conducted by
compensation consultants, adjusted for market changes since 1990 as reported  to
the Company by such consultants.

    No  deliberate  effort was  made to  include  companies in  the consultants'
surveys which  are a  part of  either of  the comparative  indices used  in  the
Performance Graph (see page 24). The Company believes that it generally competes
for   executive   talent  with   companies  similarly   sized,  from   a  market
capitalization and revenue  standpoint, regardless  of a  company's industry  or
line  of business. Base salary for executive officers is not directly related to
Company performance; however, as discussed below, most of the remaining portions
of executive officers' compensation are  wholly dependent upon increases in  the
market price of Company Common Stock.

    CASH  INCENTIVE COMPENSATION.   As  noted above,  the Company's  annual cash
incentive plan was terminated in 1991. However, the Nominating and  Compensation
Committee  retains  authority to  recommend  cash incentive  payments  to reward
special achievements. An  example of  such a  reward is  the bonus  paid to  Mr.
Seward  for  1993 in  recognition of  the outstanding  performance of  a Company
investment portfolio which is Mr. Seward's responsibility.

                                       17
<PAGE>
    LONG-TERM  COMPENSATION  PLAN.    Development  of  the  Company's  long-term
compensation  plan evolved in  two stages. First,  grants of non-statutory stock
options were made in  December 1990 to  vest in thirds in  1991, 1992 and  1993;
most  of these  were "premium" stock  options, or options  whose exercise prices
were above the market price on the date of grant, so that significant  increases
in the Company's stock price would be required before the options had value. The
market  price of Company Common  Stock was $23.25 when  these option grants were
made and the option exercise prices range up to $30.22. All of these options are
fully vested. The number of options granted and the various exercise prices were
not determined  on the  basis of  any formula;  they reflected  the  Committee's
subjective  judgment after considering the then  current market price of Company
Common Stock, the  Committee's judgment as  to the period  of time required  for
implementation  of the Company's new strategy, and the Committee's estimation of
stock price increases likely to occur over the ten-year life of the options. The
Committee took  into consideration  the  number, exercise  prices and  terms  of
existing  options in determining the size of the grants made in 1990, as well as
the various exercise price thresholds.

    The second stage in developing  the long-term compensation plan occurred  in
1991  when  the annual  cash  incentive plan  was  terminated and  a  program of
restricted stock awards was designed and implemented to reinforce the  long-term
emphasis  of the earlier  stock options. The restricted  stock awards granted in
1991 were in three tranches, with vesting first conditioned on the market  price
of  Company Common  Stock attaining an  average over  twenty consecutive trading
days of  $26.00,  $30.00  and  $35.00 per  share,  respectively.  These  vesting
thresholds  represented market prices from 17% to  58% above the market price of
$22.125 on the  date the restricted  stock awards were  granted. The  prescribed
market price thresholds which constitute the performance vesting requirements of
the  restricted stock awards were achieved in 1991, 1992 and 1993, respectively.
Once performance vesting  occurs, an  additional "time  vesting" period  begins;
each  restricted stock award tranche finally  vests in thirds, generally, at the
end of the first, second and third years of the time vesting period.

    The overall long-term compensation plan  was intended to replace the  former
annual  cash bonus  program over a  five-year period  and to assure  that only a
sustained increase in shareholder value would provide a comparable reward to the
executive officers.  The  number  of  shares  of  restricted  stock  awarded  to
executive  officers was determined  by reference to  the historical cash bonuses
paid by  the Company;  aggregate performance  vesting threshold  values for  all
tranches of restricted stock were intended to relate to the amount of cash bonus
compensation  which would otherwise be paid over the 5-year intended life of the
long-term compensation  program, assuming  historical  cash bonus  amounts  were
projected into the future. At the time the plan was fully implemented, potential
ownership  by  the  executive  officers from  the  restricted  stock  awards and
outstanding stock options was 6.5% of  the total shares of Company Common  Stock
outstanding.  The Nominating and Compensation  Committee believes providing this
level of stock  ownership incentive strongly  aligns shareholder and  management
interests.

    The  Summary Compensation Table and the Table of Aggregated Option Exercises
and Year-End Values,  beginning on pages  11 and 14,  respectively, reflect  the
results  of  this  redesigned  compensation  program  for  the  Company's  Chief
Executive Officer  and  the  two  other executive  officers  who  are  corporate
officers  of  the  Company. As  footnote  8  to the  Summary  Compensation Table
explains, SEC rules require that the full value of restricted stock be shown  as
an  "LTIP  Payout"  in the  year  that  it performance  vests,  even  though the
Company's executive  officers do  not become  entitled to  the restricted  stock
until one to three years after performance vesting.

    In  the context of revisions to the Company's strategic plan which the Board
of Directors approved in early  1995, the Nominating and Compensation  Committee
reviewed  the  long-term compensation  program  described above  and  decided to
accelerate the time  vesting of two  tranches of restricted  stock awards  which
remained  unvested as of December 31, 1994; absent acceleration, time vesting of
one of the  tranches would have  occurred in October  1995 and of  the other  in
October  1996. The  Committee concluded  that the  restricted stock  awards have
achieved the  Committee's objective  of creating  incentives for  the  Company's
management    to   increase   shareholder    value.   The   Committee   believes

                                       18
<PAGE>
that the  extent of  management's  stockholdings is  such that  their  continued
attention  to  enhancing  shareholder  value  can  be  expected;  therefore, the
Committee believes that the acceleration of  time vesting of the final  tranches
of restricted stock will not adversely affect management's performance.

    In  early  1995  the  Committee  also  approved  severance  arrangements for
executive officers who are  corporate officers of  the Company. These  severance
arrangements  will  apply only  if an  officer's employment  is terminated  as a
result  of   a   corporate   restructuring   which   does   not   constitute   a
"change-of-control" as described on page 15 above. In February 1995, the Company
announced  an  intention to  consider such  a restructuring.  Severance payments
would be 2.5  times base salary;  this constitutes less  than the amounts  which
would be owing in the event of a "change-of-control."

CEO COMPENSATION

    The  compensation of the Company's CEO  is determined in accordance with the
policies outlined above for all executive officers. In 1994, he received a  base
salary targeted at the median of salaries paid for comparable positions at other
non-manufacturing  general industrial  and financial  services companies.  He is
also a participant  in the Company's  long-term, stock-based compensation  plan.
Pursuant to such plan, the Company has reported long-term incentive plan payouts
for the CEO valued at the market price of restricted stock on the date it became
performance vested. As discussed above under "Compensation Policies -- Long-Term
Compensation   Plan,"  generally,  none  of  the  value  shown  in  the  Summary
Compensation Table for a  particular year as an  "LTIP Payout" was available  to
the  CEO  in  that  year.  It becomes  available  to  him  in  installments over
succeeding years, if  employment with the  Company continues. The  value of  the
portion  of each performance  vested award which time  vests in subsequent years
could be different than the value shown, depending upon whether the market price
of Company Common Stock increases, declines or remains the same. Measurements of
Company performance are not a significant factor in establishing the CEO's  base
salary; however, substantially all of the remainder of the CEO's compensation is
wholly  dependent upon sustained increases in the market price of Company Common
Stock.

OTHER COMPENSATION PLANS

    The Company  has  adopted  certain  employee  benefit  plans  in  which  the
executive  officers are permitted to participate on  the same terms as all other
employees who  meet  applicable  eligibility  criteria,  subject  to  any  legal
limitations  on the amounts that may be  contributed or the benefits that may be
payable under the plans. Currently, the Company offers a 401(k) Savings Plan and
a Money Purchase Pension Plan, both of which are defined contribution plans.

    The Company  has entered  into supplemental  retirement agreements  ("SERP")
with  certain highly paid executive officers to provide tax deferred accruals of
amounts proportionate  to  the  benefits  available  to  non-highly  compensated
participants  in  the  Company's  plans  (as  adjusted  based  upon compensation
levels), but which exceed  benefits permitted under the  Company's plans due  to
certain  tax law limitations.  Amounts accrued for the  benefit of the Company's
CEO and other  executive officers under  SERPs are  shown in footnote  9 to  the
Summary  Compensation Table on page 13.  The SERPs are unfunded; amounts payable
represent unsecured liabilities  of the  Company subject  to the  claims of  the
Company's other creditors.

COMPLIANCE WITH INTERNAL REVENUE CODE SECTION 162(M)

    Section  162(m) of the  Internal Revenue Code, which  took effect January 1,
1994, generally  disallows  an income  tax  deduction to  public  companies  for
compensation  over $1  million annually  paid to  the Company's  Chief Executive
Officer or to other executive officers named in the Summary Compensation  Table.
Qualifying  performance-based compensation will not  be subject to the deduction
limit if certain requirements are met. The Company believes that all outstanding
stock options and restricted  stock awards respecting  Company Common Stock,  as
well  as the stock option  plans pursuant to which  such options and awards have
been granted, qualify for an exemption from the deduction limit. Based upon  the
current   levels  of  non-performance  based   compensation  for  the  Company's

                                       19
<PAGE>
executive officers,  the deduction  limit is  not expected  to have  a  material
impact  on the Company in  1995. The Company currently  intends to structure and
administer future performance-based compensation of its executive officers in  a
manner that complies with the new tax rules.

               SUBMITTED BY NOMINATING AND COMPENSATION COMMITTEE

                           David W. Kemper, Chairman
                                 Lan C. Bentsen
                                 John C. Gamble
                               Michael E. Herman
                             John H. Robinson, Jr.
                               Dennis R. Stephen

                     SUBSIDIARIES -- EXECUTIVE COMPENSATION

LABONE, INC.

    Mr.  Hood is Chief  Executive Officer of LabONE,  Inc. ("LabONE"). LabONE is
82% owned by the Company. The remaining 18% of LabONE's stock is publicly  held.
Mr. Hood is not a corporate officer or employee of the Company. His compensation
is  determined  pursuant to  LabONE's  executive compensation  program  which is
administered by the Compensation Committee of LabONE's Board of Directors. While
the Company's Chief  Executive Officer  is Chairman  of this  Committee and  two
other  Company directors are  members, the Committee's  membership also includes
three individuals who are not directors,  officers or employees of the  Company.
LabONE's Compensation Committee operates independently of the Company's Board of
Directors.   That  Committee's  policies  respecting  LabONE  executive  officer
compensation, as reported  by LabONE's Compensation  Committee to the  Company's
Board  of Directors,  are set  forth below.  Compensation decisions  by LabONE's
Compensation Committee are entirely unrelated to the Company's performance,  but
they are, to the extent described below, related to LabONE's performance.

    The  philosophy  governing LabONE's  executive  compensation is  based  on a
belief that management and LabONE stockholders have a common goal --  increasing
the  value of LabONE common stock. The business strategy for achieving this goal
is expressed in LabONE's mission statement:

    "LabONE is dedicated to maximizing the return on investment for [LabONE]
    stockholders  .  .  .  to  providing  the  lowest-cost,  highest-quality
    laboratory  testing  services for  [its] clients  . .  . to  providing a
    working environment  that  emphasizes accountability  for  results,  and
    rewards employees based on their contributions to LabONE's success."

    Three  principal elements of LabONE's executive compensation -- base salary,
annual incentive plan, and stock options -- are used to motivate and reward  the
accomplishment  of annual  corporate objectives, reinforce  a strong orientation
toward operating excellence, provide variability  in individual awards based  on
contributions  to  business  results, and  maintain  a  competitive compensation
package to attract, retain and motivate individuals of the highest  professional
quality.

                                       20
<PAGE>
    Salary  ranges were developed based on  a survey initially conducted in 1986
by an independent consultant and updated in 1989. Base salaries are targeted  at
the  60th to 65th percentile of pay  for comparable positions in "All Industrial
Base Salaries" surveyed by the consultant. In determining base salary levels  in
July  1993,  LabONE's Compensation  Committee considered  individual performance
evaluations. Measurements related to LabONE's performance are not a  significant
factor  in base salary decisions since they  are the sole factors in determining
incentive awards and the value of stock options.

    LabONE's Annual Incentive Plan was revised in 1994 to meet the objectives of
motivating and  rewarding the  accomplishment of  strong operating  results.  An
after-tax return on equity minimum is established at the beginning of the fiscal
year  by the LabONE Compensation Committee, which minimum is then expressed as a
net income threshold. No incentive payments  are made if the minimum net  income
threshold  is not met. This  net income threshold emphasizes  the areas on which
management can have  the greatest  impact: revenue and  expenses. The  incentive
pool  is established  as an  increasing percentage of  the net  income earned by
LabONE over the  minimum threshold.  Approximately ninety percent  (90%) of  the
incentive  pool  is  distributed  in cash  ratably  to  designated  officers and
managers at year end based  on a weighting of  positions and base salaries.  The
remaining  ten percent (10%) is distributed to outstanding performers within the
eligible group, based on the recommendation of LabONE's Chief Executive  Officer
to  its Compensation Committee. No bonuses  were paid under the Annual Incentive
Plan for 1994.

    The LabONE Compensation Committee, as  well as LabONE's Board of  Directors,
believes  that  significant  stock  ownership,  through  stock  options,  by key
employees and  directors is  a  major incentive  in  aligning the  interests  of
employees  and stockholders, because  value is only provided  if the stock price
increases and  because stock  options  have an  effective long-term  reward  and
retention function.

    LabONE  stockholders  approved  a  Long-Term  Incentive  Plan  in  1987  and
increases in the  number of  shares which  may be  issued under  that plan  were
approved  by  stockholders  in 1991  and  in  1994. Under  this  plan,  ten year
non-qualified stock  options are  granted to  executive officers  and other  key
employees  when they are hired or promoted into eligible positions. These grants
are made on  a one-time  basis with  vesting to  occur over  periods from  three
months to five years.

    Mr.  Hood's compensation as Chief Executive Officer of LabONE was determined
by negotiation of an employment agreement at the time of his initial  employment
with  LabONE in August 1993, which employment agreement was subsequently amended
in November  1993. See  "Employment Agreements;  Termination of  Employment  and
Change-of-Control   Compensation  Arrangements  --  Subsidiaries  --  Employment
Agreements; Change-of-Control" for a description of the employment agreement  as
amended.  A significant portion of Mr.  Hood's compensation under his employment
agreement is  represented  by  LabONE  stock options  which  tie  his  level  of
compensation  to LabONE's future stock performance,  as Mr. Hood's expertise was
procured in order to  lead LabONE's expansion  efforts into clinical  diagnostic
testing.

RESPONSE TECHNOLOGIES, INC.

    Dr.  West is Chief Executive Officer of Response Technologies, Inc. ("RTK"),
which is 59%  owned by  the Company.  Dr. West  owns approximately  8% of  RTK's
outstanding common stock and the remaining 33% is publicly held. Dr. West is not
a  corporate officer or employee of  the Company. His compensation is determined
pursuant to RTK's executive  compensation program which  is administered by  the
Compensation  Committee  of  RTK's  Board  of  Directors.  While  three  Company
directors serve on RTK's Compensation Committee, the Committee's membership also
includes three individuals who are not  directors, officers or employees of  the
Company; it operates independently of the Company's Board of Directors. Policies
respecting RTK executive officer compensation as reported to the Company's Board
of  Directors by RTK's Compensation Committee, are set forth below. Compensation
decisions  by  RTK's  Compensation  Committee  are  entirely  unrelated  to  the
Company's  performance, but they are, to  the extent described below, related to
RTK's performance.

                                       21
<PAGE>
    The business operations of RTK  were significantly restructured during  1989
and  1990, resulting in  a redirection to provide  clinical support services for
oncologists through a network of IMPACT-Registered Trademark- Centers. Under the
direction of  a  reorganized  Board  of  Directors,  management  personnel  were
identified to develop the IMPACT-Registered Trademark- Center system.

    In  order to attract and retain  the highly qualified medical, financial and
operations executives needed to effect RTK's  new business plan during a  period
when   RTK's   cash   resources   were   dedicated   to   the   growth   of  the
IMPACT-Registered Trademark- Centers, the compensation program has emphasized an
equity-based approach involving significant grants  of stock options to its  key
executives.

    RTK's   performance,   measured   by  such   factors   as   revenue  growth,
IMPACT-Registered Trademark- Center  development and results  of operations,  is
taken  into  consideration  in  determining base  salaries  for  RTK's executive
officers. RTK's Compensation Committee has not attempted to determine a range of
compensation that  would  be  competitive  with a  reference  group  of  similar
positions   or  similar  organizations   because  of  the   emphasis  on  equity
compensation. Dr. West is  a participant in RTK's  Executive Incentive Plan  and
Stock  Option Program described  below. However, no bonus  or stock options were
granted or awarded to Dr. West for or during 1994.

    In mid-1992,  RTK's  Compensation Committee  decided  to develop  an  annual
incentive  plan for RTK's  senior management and  executive group, including Dr.
West, which permits  participants to  share in improvements  in RTK's  earnings.
Under  this plan, which became effective January 1, 1993, each participant has a
target bonus ranging from 10% to 25% of salary and a maximum bonus ranging  from
50% to 100% of salary. If RTK's earnings before interest and taxes ("EBIT") meet
a target approved by RTK's Compensation Committee for the year, the target bonus
will  be paid. If  the target is exceeded,  then 8% of EBIT  above that level is
added to the  pool until  each participant's  maximum bonus  is achieved.  RTK's
Compensation  Committee may also set  an EBIT level below  the target at which a
prorated portion of the target bonus can be paid. Because there is a very direct
relationship between RTK's performance and  the rewards available in this  plan,
RTK's Compensation Committee believes it will encourage behavior that is aligned
with shareholder interests. Because RTK's 1994 target EBIT was not met, no bonus
payments were made for 1994.

    RTK's Compensation Committee has established a 1995 target EBIT for purposes
of  the annual incentive plan, and has approved the payment of pro-rated bonuses
in the event actual EBIT is between 50% and 100% of the target EBIT. The maximum
bonuses provided for in the annual incentive plan as originally adopted would be
earned if actual 1995 EBIT is $4 million. In addition, five percent (5%) of EBIT
in excess of $4 million will be added to the bonus pool, without any  limitation
on the size of the pool.

    RTK's  Compensation Committee considers  the use of stock  options to be the
foundation of  RTK's executive  compensation program,  by providing  significant
financial  incentives  in  return  for  the  risks  assumed  by  those  who have
participated in the redirection  of RTK's business. Through  RTK's use of  stock
options  for compensation purposes, Dr. West's compensation (other than his base
salary shown  in  the  Summary  Compensation Table)  is  wholly  dependent  upon
sustained increases in the market price of RTK common stock.

    During the development of RTK's IMPACT-Registered Trademark- Center network,
RTK's   Compensation  Committee   believes  the   most  important   measures  of
performances  in  determining  executive  compensation  are  internal  measures:
increases  in  revenues  and earnings,  numbers  of Centers  opened,  numbers of
patients accrued,  and  development  of  staff  and  systems  to  support  RTK's
business.  The bonus plans  are designed to reward  achieving these shorter term
operational goals.  RTK's Compensation  Committee believes  that over  the  long
term,  RTK's stock option plan  serves to align the  interests of RTK management
and its shareholders by tying  the eventual value of  the options to the  market
price of RTK's stock.

                            ------------------------

                                       22
<PAGE>
    While  the foregoing discussion  of the compensation  policies of LabONE and
RTK is made over the names of the Directors of Seafield Capital Corporation,  in
compliance  with SEC rules, it  has not been prepared  by the Company's Board of
Directors; as indicated above,  the discussions of  LabONE and RTK  compensation
policies  are summaries of reports submitted to the Company's Board of Directors
by LabONE's and RTK's Compensation Committees.

                                SUBMITTED BY THE
                          SEAFIELD CAPITAL CORPORATION
                               BOARD OF DIRECTORS

                            W. T. Grant II, Chairman
                                 Lan C. Bentsen
                                 John C. Gamble
                                  W. D. Grant
                               Michael E. Herman
                               P. Anthony Jacobs
                                David W. Kemper
                             John H. Robinson, Jr.
                                James R. Seward
                               Dennis R. Stephen

                                       23
<PAGE>
                               PERFORMANCE GRAPH

               COMPARISON OF FIVE YEAR CUMULATIVE TOTAL RETURN AMONG
                       SEAFIELD CAPITAL CORPORATION, THE
             NASDAQ COMPOSITE INDEX AND THE RUSSELL 2000 INDEX. (1)

The  graph  below  assumes  $100  was  invested  12/31/89  and  dividends   were
reinvested.

    NOTE:  The  stock  price  performance  shown  on  the  graph  below  is  not
    necessarily indicative of future price performance.

EDGAR REPRESENTATION OF DATA POINTS USED IN PRINTED GRAPHIC

<TABLE>
<CAPTION>
           SEAFIELD     NASDAQ    RUSSEL 2000
<S>        <C>        <C>         <C>
1989         $100.00     $100.00       $100.00
1990          $65.86      $84.92        $80.49
1991          $89.52     $136.28       $117.51
1992         $114.20     $158.58       $139.21
1993         $119.31     $180.93       $165.52
1994         $118.92     $176.91       $162.51
</TABLE>

<TABLE>
<CAPTION>
YEAR END DATA                                       1989       1990       1991       1992       1993       1994
- ------------------------------------------------  ---------  ---------  ---------  ---------  ---------  ---------
<S>                                               <C>        <C>        <C>        <C>        <C>        <C>
Seafield Capital Corporation                      $     100  $   65.86  $   89.52  $  114.20  $  119.31  $  118.92
NASDAQ Composite Index                                  100      84.92     136.28     158.58     180.93     176.91
Russell 2000 Index (1)                                  100      80.49     117.51     139.21     165.52     162.51
<FN>
- ------------------------

(1)  The Russell 2000 Index is  an index of companies  the mean of whose  market
     capitalizations  approximates  that of  the Company.  It has  been selected
     because the diverse nature of  the Company's businesses causes the  Company
     to believe that it cannot reasonably identify a peer group of companies for
     comparison  and the Company  does not use a  published industry or line-of-
     business index.  The  Company believes  that  an index  of  companies  with
     similar  market capitalizations provides  a good basis  for comparing total
     shareholder returns.
</TABLE>

                                       24
<PAGE>
          COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

    The  Company's   Nominating   and  Compensation   Committee   ("Compensation
Committee")  during 1994  comprised Lan C.  Bentsen, John C.  Gamble, Michael E.
Herman, David W. Kemper, John  H. Robinson, Jr. and  Dennis R. Stephen. None  of
the  persons who served as members of the Compensation Committee during 1994 (a)
are employees or officers  of the Company  or any of  its subsidiaries, (b)  are
former  officers  of the  Company or  any of  its subsidiaries,  or (c)  had any
relationship or  transaction with  the Company  requiring disclosure  under  the
SEC's rules, except as discussed below.

    The   Company  and  certain  of  its  subsidiaries  conduct  normal  banking
transactions in the usual course of  business with, among others, Commerce  Bank
of  Kansas City, N.A.  ("Commerce") and Boatmen's First  National Bank of Kansas
City ("Boatmen's"). Mr. Kemper is Chief Executive Officer of Commerce's  holding
company. Mr. Herman is a director of Boatmen's and Mr. Robinson is a director of
Commerce.  In  the Company's  opinion, charges  for  services rendered  by these
banking institutions are commensurate with the costs charged by other  financial
institutions for similar services. The Company and its subsidiaries may continue
to use both of these banking institutions for certain services in 1995.

    Mr. W. T. Grant II, Chairman of the Board and Chief Executive Officer of the
Company,  serves as  a director  of Commerce  Bancshares, Inc.,  a company whose
chief executive officer, David  W. Kemper, serves as  Chairman of the  Company's
Nominating and Compensation Committee.

              RATIFICATION OF APPOINTMENT OF INDEPENDENT AUDITORS

    The  firm of KPMG Peat Marwick LLP  has been the independent auditors of the
Company since 1959. The Board of Directors has again appointed KPMG Peat Marwick
LLP to serve as the Company's independent auditors for the year ending  December
31,  1995. While not required to do so, the Board of Directors is submitting the
selection of the independent auditors for ratification in order to ascertain the
views of  the shareholders.  If the  selection  is not  ratified, the  Board  of
Directors  will reconsider its selection. Ratification of the selection requires
the affirmative vote  of the  holders of  a majority  of the  shares of  Company
Common Stock represented in person or by proxy at the Annual Meeting.

    THE BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE FOR RATIFICATION OF
THIS APPOINTMENT.

    A  representative of  KPMG Peat  Marwick LLP will  be present  at the Annual
Meeting to make a statement if he desires to do so and to respond to appropriate
questions.

                             SHAREHOLDER PROPOSALS

    Shareholder proposals intended for inclusion  in the proxy materials of  the
Company  for the  1996 Annual  Meeting must  be received  by the  Company at its
executive offices on or before  December 15, 1995, in  order to be eligible  for
inclusion therein.

                                 OTHER BUSINESS

    As  of the date of this Proxy Statement, the Board of Directors is not aware
of any matters to be presented for action at the Annual Meeting other than those
described herein. If any other matters should come before the meeting, it is the
intention of each of the persons named on the enclosed form of proxy to vote all
duly executed proxies in accordance with their best judgment on such matters.

                                          By Order of the Board of Directors

                                          Steven K. Fitzwater,
                                          SECRETARY

Kansas City, Missouri
April 17, 1995

                                       25
<PAGE>
                          SEAFIELD CAPITAL CORPORATION
                     PROXY SOLICITED THE BOARD OF DIRECTORS


  The undersigned hereby constitutes and appoints William D. Grant and W.T.
Grant II, and each of them, jointly and severally, as proxies, with full power
of substitution and revocation, for and in the name and place of the
undersigned, to vote all of the shares of $1.00 par value common stock of
Seefield Capital Corporation, a Missouri corporation (the "Company"), which the
undersigned is entitled to vote at the Annual Meeting of shareholders of the
Company to be held at the Westin Crown Center Hotel - Shawnee Mission Room, One
Pershing Road, Kansas City, Missouri, on Wednesday, May 17, 1995, at 10:00 a.m.
local time, and at any adjournment or adjournments thereof, as fully and with
the same effect as the undersigned might or could do if personally present, as
indicated on the reverse side of this card.

                       (To be signed on the Reverse Side)


                                                              (See Reverse Side)



                                        2
<PAGE>
/X/ Please mark your votes as in

    this example.


ELECTION OF DIRECTORS         NOMINEES: JOHN C. GAMBLE, MICHAEL E. HERMAN, JAMES
                              R. SEWARD - EACH FOR A THREE (3) YEAR TERM.

                              (CUMULATIVE VOTING APPLIES - SEE PROXY STATEMENT)


FOR all Nominees         WITHHOLD as to all Nominees

      / /                             / /


FOR all Nominees, except vote withheld from the following nominee(s):



- -------------------------------------------





Signature(s) __________________________________________________________________


                                        FOR       AGAINST        ABSTAIN
2. Approval of
   Independent                          / /         / /             / /
   Auditors

3. In their discretion
   upon all other                       / /         / /             / /
   matters

The Board of Directors recommends a vote FOR each of the nominees for election
as directors and FOR each of the proposals.  If you sign and return this proxy
it will be voted in the manner directed herein.  IF YOU DO NOT DESIGNATE HOW
YOUR SHARES ARE TO BE VOTED THE PROXY WILL BE VOTED FOR EACH NOMINEE AND EACH
PROPOSAL.

If you do not mark any boxes in items (1) through (3), you will be deemed to
have granted authority to the named proxies to vote for the election of the
three nominated directors, to vote for the proposal in Item 2 and to vote in
their discretion on all matters which may properly come before the meeting.

PLEASE MARK, SIGN, DATE AND RETURN THE PROXY CARD PROMPTLY USING THE ENCLOSED
ENVELOPE.


Date _______________________, 1995


NOTE:  Please sign name exactly as name appears hereon.  Joint owners should
each sign.  When signing as attorney, executor, administrator, trustee or
guardian, please give full title as such.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission